Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
3.140
-0.170 (-5.14%)
At close: Mar 9, 2026, 4:00 PM EDT
3.190
+0.049 (1.58%)
After-hours: Mar 9, 2026, 4:43 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $190.20 million as of March 9, 2026. Its market cap has increased by 129.41% in one year.
Market Cap
190.20M
Enterprise Value
85.59M
1-Year Change
129.41%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $190.20M, a decrease of -69.24%. That is a compound annual growth rate of -22.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 200.50M | 56.87% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 214.23M |
| Cibus | 213.48M |
| Protalix BioTherapeutics | 210.70M |
| ProMIS Neurosciences | 209.84M |
| Elicio Therapeutics | 203.23M |
| Arcturus Therapeutics Holdings | 202.09M |
| Galectin Therapeutics | 199.87M |
| Editas Medicine | 195.24M |